Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:2 Issue:3 Number:30 ISSN#:2563-5476
ACE Report #4744
Ace Report Cover Spine

The role of alendronate in osteoporosis patients undergoing PLIF

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial

J Neurosurg Spine. 2011 Apr;14(4):500-7. doi: 10.3171/2010.11.SPINE10245. Epub 2011 Jan 28

Contributing Authors: K Nagahama M Kanayama D Togawa T Hashimoto A Minami

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


40 osteoporosis patients undergoing single-level posterior lumbar interbody fusion were randomized to receive alendronate or vitamin D (alfacalcidol) to determine the impact of bisphosphonates on the spinal fusion recovery process. Following clinical, radiographic, and biochemical evaluations over a 12 month period, the results indicated that greater solid fusion, less cage subsidence, and no vert...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.